Scotland first in UK to approve ‘take at home’ MS drug

Source BBC: A new treatment for patients with multiple sclerosis has been approved by the Scottish Medicines Consortium (SMC).

Zeposia has been developed for adult patients with relapsing-remitting MS, where the patient has flare-ups followed by periods of remission.

It is a treatment option which may reduce the need to have treatment administered in a clinical setting.

It is one of four drugs which have been newly-approved.

Ozanimod – Zeposia is manufactured by the company Bristol Myer Squibb. Taken orally once a day it provides the advantage of being taken at home and avoiding clinical appointments during the coronavirus pandemic. Read on.